Treatment of BK virus-associated nephropathy with CMX001 after kidney transplantation in a young child

Pediatric Transplantation

Volumn 18, Issue 7, 2014, Pages E227-E231

  Reisman, Lewis ^a   Habib, Sabeen ^a   McClure, Gloria B ^a   Latiolais, Lisa S ^a   Vanchiere, John A ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

BK virus; BKVAN; CMX001; Nephropathy

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; BRINCIDOFOVIR; CIPROFLOXACIN; CREATININE; LEFLUNOMIDE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; VALGANCICLOVIR; VIRUS DNA;

ARTICLE; ASYMPTOMATIC BACTERIURIA; BK VIRUS; BK VIRUS ASSOCIATED NEPHROPATHY; CASE REPORT; CHILD; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRESCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

EID: 85027939191     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12340     Document Type: Article

References (30)

1. REPLOEG MD, STORCH GA, CLIFFORD DB. BK virus: A clinical review. Clin Infect Dis 2001: 33: 191-202.
2. MYLONAKIS E, GOES N, RUBIN R.H., COSIMI AB, COLVIN RB, FISHMAN JA. BK virus in solid organ transplant recipients: An emerging syndrome. Transplantation 2001: 72: 1587-1592.
3. MATOSSIAN D, COHN RA, LANGMAN C.B., ALI FN. Obstructive uropathy is associated with polyoma virus viremia in pediatric kidney transplantation. Pediatr Transplant 2012: 16: 729-734.
4. FISHMAN JA. BK virus nephropathy - Polyomavirus adding insult to injury. N Engl J Med 2002: 347: 527-530.
5. KUYPERS DR, VANDOOREN AK, LERUT E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005: 5: 1997-2004.
6. WILLIAMS JW, JAVAID B, KADAMBI P.V., et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005: 352: 1157-1158.
7. WOJCIECHOWSKI D, CHANDA R, CHANDRAN S., et al. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation 2012: 94: 1117-1123.
8. JOHNSTON O, JASWAL D, GILL J.S., DOUCETTE S., FERGUSSON DA, KNOLL GA. Treatment of polyomavirus infection in kidney transplant recipients: A systematic review. Transplantation 2010: 89: 1057-1070.
9. RINALDO CH, GOSERT R, BERNHOFF E., FINSTAD S, HIRSCH HH. 1-O-hexadecycloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells. Antimicrob Agents Chemother 2010: 54: 4714-4722.
10. PRICHARD MN, KERN ER, HARTLINE C.B., LANIER ER, QUENELLE DC. CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections. Antimicrob Agents Chemother 2011: 55: 4728-4734.
11. POMERANTZ BJ, HASSELL JA. Polyomavirus and simian virus 40 large T antigens bind to common DNA sequences. J Virol 1984: 49: 925-937.
12. MONTYJARVI RA, ARSTILLA PP, MEURMAN OH. Hemagglutination by BK virus, a tentative new member of the papovavirus group. Infect Immun 1972: 6: 824-828.
13. MACKENZIE EF, POULDING JM, HARRISON P.R., AMER B. Human polyoma virus (HPV) - a significant pathogen in renal transplantation. Proc Eur Dial Transplant Assoc 1978: 15: 352-360.
14. MAYR M, NICKELEIT V, HIRSCH H.H., DICKENMANN M., MI-HATSCH MJ, STEIGER J. Polyomavirus BK nephropathy in a kidney transplant recipient: Critical issues of diagnosis and management. Am J Kidney Dis 2001: 38: 1277-1286.
15. BOHL DL, BRENNAN DC. BK virus nephropathy and kidney transplantation. Am J Nephrol 2007: 2: S36-S46.
16. HIRSCH HH, KNOWLES W, DICKENMANN M., et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002: 347: 488-496.
17. DRACHENBERG RC, DRACHENBERG CB, PAPADIMITRIOU J.C., et al. Morphological spectrum of polyoma virus disease in renal allografts: Diagnostic accuracy of urine cytology. Am J Transplant 2001: 1: 373-381.
18. DRACHENBERG CB, PAPADIMITRIOU JC, HIRSCH H.H., et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004: 4: 2082-2092.
19. NICKELEIT V, MIHATSCH MJ. Polyomavirus nephropathy in native kidneys and renal allografts: An update on an escalating threat. Transpl Int 2006: 19: 960-973.
20. BENNETT WM, MEYER L, BATIUK TD. Surveillance and modification of immunosuppression minimizes BK virus nephropathy. Am J Nephrol 2010: 32: 10-12.
21. HIRSCH HH, BRENNAN DC, DRACHENBERG C.B., et al. Polyoma-virus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005: 79: 1277-1286.
22. CANIVET C, ROSTAING L, GALVANI S., et al. Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome. Int Immunopharmacol 2009: 9: 1131-1136.
23. NICOLAE L. Leflunomide use in renal transplantation. Curr Opin Organ Transplant 2009: 14: 370-374.
24. CABELLO V, MARGARIT N, DIAZ PEDRERO M, BERNAL G, PERE-IRA P, GENTIL MA. Treatment of BK virus-associated nephropathy with cidofovir in renal transplantation. Transplant Proc 2008: 40: 2930-2932.
25. HUA DK, HOWARD K, CRAIG J.C., CHAPMAN JR, WONG G Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients. Transplantation 2012: 93: 188-194.
26. IZZEDINE H, LAUNAY-VACHER V, DERAY G Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 2005: 45: 804-817.
27. ANYAEGBU EI, ALMOND PS, MILLIGAN T, ALLEN W.R., GHA-RAYBEH S, AL-AKASH SI. Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients. Pediatr Transplant 2012: 16: E19-E24.
28. DROPULIC LK, COHEN JI. Update on new antivirals under development for the treatment of double-stranded DNA virus infections. Clin Pharmacol Ther 2010: 88: 610-619.
29. RICE AD, ADAMS MM, LAMPERT B, et al. Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans. Viruses 2011: 3: 63-82.
30. PAPANICOLAOU G, KOLITSOPOULOS Y, YOUNG J., et al. BK virus-associated nephropathy, an under-recognized cause of renal dysfunction in severely immunosuppressed hematopoietic stem cell transplant (HSCT) patients: Report of 5 cases and the potential role of CMX001 for treatment. Biol Blood Marrow Transplant 2013: 19: S302-S303.